Release Date: 25/02/22 09:40 Summary: Update on Scheme Booklet Price Sensitive: Yes Download Document 1.08MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%